acroprep advance dna binding plate ensure dna recovery and quality-欧洲杯线上买球

ensure dna recovery and quality

this study demonstrates that research labs can achieve a substantial consumable cost savings in sample preparation without sacrificing dna yield, purity, or quality

 

challenges

 

dna binding plates are employed as a basis for automated dna isolation from blood for a broad variety of diagnostic tests. such assays are used for disease detection, prognosis, and monitoring. although these tests often utilize the same well-established automation platforms as basic research, they require a higher degree of robustness and sample consistency in terms of dna yield, concentration, and quality.

 

solution

 

there are several product options available in the market containing dna binding plates and a complete set of buffers. although vacuum filtration is more user-friendly and easily automated, centrifugation is still the primary method used to ensure dna recovery and quality. an alternative to pre-packaged kits is the use of individual components, such as pall acroprep advance dna binding plates which utilize standard glass fiber technology for genomic dna isolation and purification. this platform offers additional flexibility as it can be used with a variety of reagent kits and, therefore, customized to your application requirements. additionally, these plates offer a consistent and reproducible isolation of high yield and good quality gdna from human blood using either vacuum or centrifugation.

 

samples of fresh blood (edta) produced the best gdna yield at 3.7 µg/well (100 µl blood). that represents up to 86% dna recovery calculated based on wbc concentration in the starting blood sample. inter-plate performance for dna yield was similar for all nine plates used in the study varying in the range of one sd between 79-86%. intra-plate (well-to-well) consistency evaluated by cv (%) was 11% or less. the acroprep advance plates demonstrated equal to, or better, performance than the competitor’s plates when used with the qiagen gdna buffer kit.

 

dna can help diagnose or indicate a susceptibility to having or passing on a wide range of diseases, such as cystic fibrosis, huntington's disease, sickle cell anemia, and tay-sachs. fresh or frozen blood is the most common specimen used for this type of analysis, and sample preparation is considered one of the more critical factors in achieving the levels of sensitivity and specificity required. fast and efficient dna isolation from whole blood is essential to obtain the necessary high quality starting material.

 

 

many research labs achieve high levels of dna sample yield, concentration, and quality while obtaining fast and efficient sample preparation using complete kits that include binding plates and buffers. pall offers an alternative to this approach by selling dna binding plates as a separate component that can be used with the solution kits of many manufacturers.

 

a key advantage is that the total cost of the pall dna binding plates and buffers can be 50% of the cost of the complete kits that incorporate binding plates and buffers. additionally, such an approach offers added flexibility for your specific requirements, and the versatility to purify samples using either vacuum or centrifugation. the purpose of this study is to compare the dna recovery and purity of samples prepared with the acroprep advance dna binding plate and popular commercial buffers to samples prepared with a competitor’s plate. the two different plates were used with the same materials and methods based on vacuum filtration and using a liquid-handling robotic system popular in research facilities. the results show that dna recovery is similar for the pall plates and the competitor’s plates.

 

the six pall plates ranged from 71-86% dna recovery, while the three competitor’s plates ranged from 73-79% recovery. intra-plate (well-to-well) consistency was also similar for all nine plates with cv (%) of 11% for all nine plates, indicating that the purification process is highly reproducible. inter-plate cv (%) was also similar for all nine plates with intra-plate consistency cv (%) of 6% or less. dna purity is also at similar high levels for both pall’s and the competitor’s plates. the od260/280 ratio was in the range of between 1.73-1.83 for the six pall plates and was between 1.72-1.79 for the three competitor’s plates.

 

the inter-plate consistency for dna purity was in the range of one sd for all nine plates in the study with intra-plate consistency cv (%) within 6% or less. gel electrophoresis images indicate similar levels of quality and dna concentration on the samples produced with both the pall binding plates and the competitor’s plates. the study also clearly demonstrates the advantages of using fresh blood samples in research studies. fresh blood produced the highest yields at 3.7 μg/well. blood lysate that had been stored for 5 hours produced a lower dna yield of 2.7 μg/well. blood that had been frozen and thawed provided an even lower dna yield of 2.3 μg/well.

 

these results demonstrate that acroprep advance dna binding plates can be used in conjunction with commercially available buffers to deliver equal or better performance than a competitor’s plate. the combination of the acroprep advance dna binding plate and commercial buffers provides a 50% cost savings compared to the purchase of a complete kit.

 

this study demonstrates that research labs can achieve a substantial consumable cost savings in sample preparation without sacrificing dna yield, purity, or quality

 

results

 

acroprep advance dna binding plates provide an equal, or better, performance than competitor’s plates when used with commercially available buffers. additionally, companies have experienced dramatic savings by implementing our binding plates. acroprep advance dna binding plates plus buffers cost about 50% less than competitor’s complete kit including binding plates and buffers. but the up-front savings are only just the beginning.

 

dna yield and purity of pall’s dna binding plates is equal to or better than competitor’s plates. inter-plate and intra-plate consistency for both dna yield and purity of the samples produced with the pall plates is equal to or better than the competitor’s plates. gel electrophoresis images indicate high quality and similar dna concentration for both pall and competitor plates. and best of all, fresh blood provides the highest dna yields while blood lysate stored for 5-hours and freeze/thawed blood provide substantially lower yields. for more innovative solutions from pall’s laboratory team, contact us today.

用于空气监测和采样的过滤产品

由于对健康和环境问题的重大影响,空气质量已成为全球共同关注的问题。在全球范围内,政府监管部门设定控制我们所呼吸空气的污染状况的标准。我们从40多年前就开始研究用于空气采样和分析的过滤器的开发和生产。我们现在是全世界最大的膜类和玻纤过滤器供应商之一,专门设计用于环境监测和测试。
由于对健康和环境问题的重大影响,空气质量已成为全球共同关注的问题。在全球范围内,政府监管部门设定控制我们所呼吸空气的污染状况的标准。我们从40多年前就开始研究用于空气采样和分析的过滤器的开发和生产。我们现在是全世界最大的膜类和玻纤过滤器供应商之一,专门设计用于环境监测和测试。

使纯产品在几分钟内即可达到> 90%以上的提取利用率

颇尔离心装置可简化许多常用核酸和蛋白质样品的制备程序。这些设备,可在数分钟内为容量从50 µl到60ml的样品提供有效的富集和脱盐处理。从已开发的薄膜中进行选择,以确保具有较低的非特定生物分子粘合性,一般能够为目标生物分子提供> 90%的高提取利用率。
颇尔离心装置可简化许多常用核酸和蛋白质样品的制备程序。这些设备,可在数分钟内为容量从50 µl到60ml的样品提供有效的富集和脱盐处理。从已开发的薄膜中进行选择,以确保具有较低的非特定生物分子粘合性,一般能够为目标生物分子提供> 90%的高提取利用率。
了解更多
网站地图